US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist

15.170
+0.120+0.80%

Close Aug 26 16:00 ET

969.21MMarket Cap-3569P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-1.87%-46.06M

27.03%-45.22M

-96.26%-184.17M

-11.63%-38M

-88.62%-38.98M

-149.99%-45.21M

-194.52%-61.97M

-71.92%-93.84M

-105.88%-34.04M

-74.03%-20.67M

Net income from continuing operations

-18.03%-64.99M

28.77%-48.54M

-83.05%-237.73M

-46.03%-66.86M

-64.88%-47.66M

-86.71%-55.06M

-165.25%-68.15M

-63.54%-129.87M

-58.17%-45.79M

-105.83%-28.91M

Operating gains losses

----

--182K

--1K

----

Depreciation and amortization

7.58%142K

38.10%145K

104.71%522K

56.25%150K

117.74%135K

131.58%132K

162.50%105K

112.50%255K

200.00%96K

106.67%62K

Other non cash items

-93.90%306K

12.63%107K

2,401.14%6.6M

128.57%112K

1,047.50%1.38M

10,356.25%5.02M

102.13%95K

-96.47%264K

-99.36%49K

-88.04%120K

Change In working capital

337.02%11.13M

20.84%-4.96M

-159.05%-9.43M

-22.61%5.62M

-239.88%-4.08M

-176.28%-4.7M

-1,597.29%-6.26M

825.87%15.96M

657.52%7.26M

194.47%2.92M

-Change in receivables

292.31%102K

--0

115.12%26K

63.38%-26K

177.38%349K

960.71%297K

-81.23%295K

-Change in prepaid assets

188.79%3.13M

-113.66%-4.47M

36.90%-2.11M

432.22%2.38M

202.36%1.13M

-351.67%-3.52M

-182.97%-2.09M

-123.20%-3.34M

-191.81%-717K

-810.74%-1.1M

-Change in payables and accrued expense

807.82%7.97M

89.88%-412K

-136.54%-7.03M

-57.34%3.31M

-235.31%-5.14M

-115.68%-1.13M

-892.02%-4.07M

533.94%19.24M

3,422.27%7.75M

184.99%3.8M

-Change in other working capital

0.00%-72K

0.00%-288K

0.00%-72K

-145.28%-288K

-1.41%-72K

0.00%-72K

Cash from discontinued investing activities

Operating cash flow

-1.87%-46.06M

27.03%-45.22M

-96.26%-184.17M

-11.63%-38M

-88.62%-38.98M

-149.99%-45.21M

-194.52%-61.97M

-71.92%-93.84M

-105.88%-34.04M

-74.03%-20.67M

Investing cash flow

Cash flow from continuing investing activities

52.23%61.98M

-975.93%-143.05M

18.13%-94.25M

6.03%-169.71M

12.64%48.04M

191.58%40.71M

-250.01%-13.3M

-54.96%-115.13M

-125.16%-180.6M

582.31%42.65M

Net PPE purchase and sale

68.58%-104K

--0

-12.67%-898K

79.22%-48K

-325.26%-404K

-13.36%-331K

35.75%-115K

-207.72%-797K

-181.71%-231K

48.09%-95K

Net investment purchase and sale

51.25%62.08M

-985.32%-143.05M

18.35%-93.35M

5.94%-169.66M

13.33%48.45M

187.93%41.04M

-245.76%-13.18M

-54.43%-114.33M

-125.10%-180.37M

564.38%42.75M

Cash from discontinued investing activities

Investing cash flow

52.23%61.98M

-975.93%-143.05M

18.13%-94.25M

6.03%-169.71M

12.64%48.04M

191.58%40.71M

-250.01%-13.3M

-54.96%-115.13M

-125.16%-180.6M

582.31%42.65M

Financing cash flow

Cash flow from continuing financing activities

-96.48%108K

2,058.48%177.08M

-29.97%225.67M

664.75%198.94M

-94.69%15.46M

-32.69%3.07M

1,011.65%8.2M

157.23%322.24M

15,202.35%26.01M

149.10%290.93M

Net issuance payments of debt

----

200.00%15M

--0

----

--5M

--446K

--0

Net common stock issuance

--0

--186.27M

-57.15%125.07M

398.56%125.07M

--0

155.49%291.87M

2,398.61%25.09M

----

Net preferred stock issuance

----

73.16%76.19M

--76.19M

----

159.43%44M

--0

----

Proceeds from stock option exercised by employees

-93.16%210K

-85.45%1.19M

459.90%21.72M

411.38%9.48M

-24.38%971K

76,600.00%3.07M

1,011.65%8.2M

65.04%3.88M

73.43%1.85M

0.16%1.28M

Net other financing activities

---102K

---10.38M

45.29%-12.32M

-760.13%-11.8M

----

-171.93%-22.51M

27.90%-1.37M

----

Cash from discontinued financing activities

Financing cash flow

-96.48%108K

2,058.48%177.08M

-29.97%225.67M

664.75%198.94M

-94.69%15.46M

-32.69%3.07M

1,011.65%8.2M

157.23%322.24M

15,202.35%26.01M

149.10%290.93M

Net cash flow

Beginning cash position

3.53%91.64M

-33.91%102.83M

267.81%155.58M

-67.58%111.6M

178.28%87.08M

186.85%88.52M

267.81%155.58M

-7.84%42.3M

147.86%344.21M

12.95%31.29M

Current changes in cash

1,218.35%16.03M

83.32%-11.19M

-146.57%-52.75M

95.35%-8.77M

-92.17%24.52M

-429.43%-1.43M

-486.17%-67.06M

3,248.42%113.28M

-95.32%-188.63M

181.47%312.92M

End cash Position

23.64%107.67M

3.53%91.64M

-33.91%102.83M

-67.58%111.6M

178.28%87.08M

186.85%88.52M

267.81%155.58M

147.86%344.21M

Free cash flow

-1.35%-46.16M

27.16%-45.22M

-95.56%-185.07M

-11.01%-38.05M

-89.70%-39.39M

-147.82%-45.55M

-192.58%-62.09M

-72.32%-94.64M

-106.23%-34.27M

-72.15%-20.76M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-1.87%-46.06M	27.03%-45.22M	-96.26%-184.17M	-11.63%-38M	-88.62%-38.98M	-149.99%-45.21M	-194.52%-61.97M	-71.92%-93.84M	-105.88%-34.04M	-74.03%-20.67M
Net income from continuing operations	-18.03%-64.99M	28.77%-48.54M	-83.05%-237.73M	-46.03%-66.86M	-64.88%-47.66M	-86.71%-55.06M	-165.25%-68.15M	-63.54%-129.87M	-58.17%-45.79M	-105.83%-28.91M
Operating gains losses	----	----	--182K	--1K	----	----	----	----	----	----
Depreciation and amortization	7.58%142K	38.10%145K	104.71%522K	56.25%150K	117.74%135K	131.58%132K	162.50%105K	112.50%255K	200.00%96K	106.67%62K
Other non cash items	-93.90%306K	12.63%107K	2,401.14%6.6M	128.57%112K	1,047.50%1.38M	10,356.25%5.02M	102.13%95K	-96.47%264K	-99.36%49K	-88.04%120K
Change In working capital	337.02%11.13M	20.84%-4.96M	-159.05%-9.43M	-22.61%5.62M	-239.88%-4.08M	-176.28%-4.7M	-1,597.29%-6.26M	825.87%15.96M	657.52%7.26M	194.47%2.92M
-Change in receivables	292.31%102K	--0	--0	--0	--0	115.12%26K	63.38%-26K	177.38%349K	960.71%297K	-81.23%295K
-Change in prepaid assets	188.79%3.13M	-113.66%-4.47M	36.90%-2.11M	432.22%2.38M	202.36%1.13M	-351.67%-3.52M	-182.97%-2.09M	-123.20%-3.34M	-191.81%-717K	-810.74%-1.1M
-Change in payables and accrued expense	807.82%7.97M	89.88%-412K	-136.54%-7.03M	-57.34%3.31M	-235.31%-5.14M	-115.68%-1.13M	-892.02%-4.07M	533.94%19.24M	3,422.27%7.75M	184.99%3.8M
-Change in other working capital	0.00%-72K	0.00%-72K	0.00%-288K	0.00%-72K	0.00%-72K	0.00%-72K	0.00%-72K	-145.28%-288K	-1.41%-72K	0.00%-72K
Cash from discontinued investing activities
Operating cash flow	-1.87%-46.06M	27.03%-45.22M	-96.26%-184.17M	-11.63%-38M	-88.62%-38.98M	-149.99%-45.21M	-194.52%-61.97M	-71.92%-93.84M	-105.88%-34.04M	-74.03%-20.67M
Investing cash flow
Cash flow from continuing investing activities	52.23%61.98M	-975.93%-143.05M	18.13%-94.25M	6.03%-169.71M	12.64%48.04M	191.58%40.71M	-250.01%-13.3M	-54.96%-115.13M	-125.16%-180.6M	582.31%42.65M
Net PPE purchase and sale	68.58%-104K	--0	-12.67%-898K	79.22%-48K	-325.26%-404K	-13.36%-331K	35.75%-115K	-207.72%-797K	-181.71%-231K	48.09%-95K
Net investment purchase and sale	51.25%62.08M	-985.32%-143.05M	18.35%-93.35M	5.94%-169.66M	13.33%48.45M	187.93%41.04M	-245.76%-13.18M	-54.43%-114.33M	-125.10%-180.37M	564.38%42.75M
Cash from discontinued investing activities
Investing cash flow	52.23%61.98M	-975.93%-143.05M	18.13%-94.25M	6.03%-169.71M	12.64%48.04M	191.58%40.71M	-250.01%-13.3M	-54.96%-115.13M	-125.16%-180.6M	582.31%42.65M
Financing cash flow
Cash flow from continuing financing activities	-96.48%108K	2,058.48%177.08M	-29.97%225.67M	664.75%198.94M	-94.69%15.46M	-32.69%3.07M	1,011.65%8.2M	157.23%322.24M	15,202.35%26.01M	149.10%290.93M
Net issuance payments of debt	----	----	200.00%15M	--0	----	----	----	--5M	--446K	--0
Net common stock issuance	--0	--186.27M	-57.15%125.07M	398.56%125.07M	--0	--0	--0	155.49%291.87M	2,398.61%25.09M	----
Net preferred stock issuance	----	----	73.16%76.19M	--76.19M	----	----	----	159.43%44M	--0	----
Proceeds from stock option exercised by employees	-93.16%210K	-85.45%1.19M	459.90%21.72M	411.38%9.48M	-24.38%971K	76,600.00%3.07M	1,011.65%8.2M	65.04%3.88M	73.43%1.85M	0.16%1.28M
Net other financing activities	---102K	---10.38M	45.29%-12.32M	-760.13%-11.8M	----	----	----	-171.93%-22.51M	27.90%-1.37M	----
Cash from discontinued financing activities
Financing cash flow	-96.48%108K	2,058.48%177.08M	-29.97%225.67M	664.75%198.94M	-94.69%15.46M	-32.69%3.07M	1,011.65%8.2M	157.23%322.24M	15,202.35%26.01M	149.10%290.93M
Net cash flow
Beginning cash position	3.53%91.64M	-33.91%102.83M	267.81%155.58M	-67.58%111.6M	178.28%87.08M	186.85%88.52M	267.81%155.58M	-7.84%42.3M	147.86%344.21M	12.95%31.29M
Current changes in cash	1,218.35%16.03M	83.32%-11.19M	-146.57%-52.75M	95.35%-8.77M	-92.17%24.52M	-429.43%-1.43M	-486.17%-67.06M	3,248.42%113.28M	-95.32%-188.63M	181.47%312.92M
End cash Position	23.64%107.67M	3.53%91.64M	-33.91%102.83M	-33.91%102.83M	-67.58%111.6M	178.28%87.08M	186.85%88.52M	267.81%155.58M	267.81%155.58M	147.86%344.21M
Free cash flow	-1.35%-46.16M	27.16%-45.22M	-95.56%-185.07M	-11.01%-38.05M	-89.70%-39.39M	-147.82%-45.55M	-192.58%-62.09M	-72.32%-94.64M	-106.23%-34.27M	-72.15%-20.76M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall